These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 33916521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes.
    D'Elia G, Caliendo G, Tzioni MM, Albanese L, Passariello L, Molinari AM, Vietri MT.
    Genes (Basel); 2022 Sep 21; 13(10):. PubMed ID: 36292577
    [Abstract] [Full Text] [Related]

  • 3. Genetic testing for hereditary prostate cancer: Current status and limitations.
    Zhen JT, Syed J, Nguyen KA, Leapman MS, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B.
    Cancer; 2018 Aug 01; 124(15):3105-3117. PubMed ID: 29669169
    [Abstract] [Full Text] [Related]

  • 4. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S, Cardoso M, Paulo P, Pinheiro M, Pinto P, Santos C, Pinto C, Peixoto A, Henrique R, Teixeira MR.
    Fam Cancer; 2016 Jan 01; 15(1):111-21. PubMed ID: 26289772
    [Abstract] [Full Text] [Related]

  • 5. Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.
    Brandão A, Paulo P, Teixeira MR.
    Int J Mol Sci; 2020 Jul 16; 21(14):. PubMed ID: 32708810
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
    Chandrasekar T, Gross L, Gomella LG, Hegarty SE, Leong JY, Giri VN.
    Eur Urol Oncol; 2020 Jun 16; 3(3):291-297. PubMed ID: 31278035
    [Abstract] [Full Text] [Related]

  • 7. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.
    Wokołorczyk D, Kluźniak W, Huzarski T, Gronwald J, Szymiczek A, Rusak B, Stempa K, Gliniewicz K, Kashyap A, Morawska S, Dębniak T, Jakubowska A, Szwiec M, Domagała P, Lubiński J, Narod SA, Akbari MR, Cybulski C, Polish Hereditary Prostate Cancer Consortium.
    Int J Cancer; 2020 Nov 15; 147(10):2793-2800. PubMed ID: 32875559
    [Abstract] [Full Text] [Related]

  • 8. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S, Salami SS, Spratt DE, Kaffenberger SD, Jacobs MF, Morgan TM.
    J Urol; 2019 Aug 15; 202(2):223-230. PubMed ID: 30730411
    [Abstract] [Full Text] [Related]

  • 9. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine.
    Marino F, Totaro A, Gandi C, Bientinesi R, Moretto S, Gavi F, Pierconti F, Iacovelli R, Bassi P, Sacco E.
    Prostate Cancer Prostatic Dis; 2023 Dec 15; 26(4):655-664. PubMed ID: 36434163
    [Abstract] [Full Text] [Related]

  • 10. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.
    Wei J, Yang W, Shi Z, Lu L, Wang Q, Resurreccion WK, Engelmann V, Zheng SL, Hulick PJ, Cooney KA, Isaacs WB, Helfand BT, Lu J, Xu J.
    Prostate; 2021 Sep 15; 81(13):1002-1008. PubMed ID: 34254341
    [Abstract] [Full Text] [Related]

  • 11. Prostate Cancer Germline Variations and Implications for Screening and Treatment.
    Dias A, Kote-Jarai Z, Mikropoulos C, Eeles R.
    Cold Spring Harb Perspect Med; 2018 Sep 04; 8(9):. PubMed ID: 29101112
    [Abstract] [Full Text] [Related]

  • 12. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA, Baig MK, Milewski B, Keywan C, Guarino M, Petrelli N.
    Ann Surg Oncol; 2016 May 04; 23(5):1729-35. PubMed ID: 26727920
    [Abstract] [Full Text] [Related]

  • 13. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S, Ansley K, Delaney SD, Ramkissoon S.
    Breast Cancer Res Treat; 2020 Apr 04; 180(2):511-514. PubMed ID: 32040686
    [Abstract] [Full Text] [Related]

  • 14. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.
    J Natl Compr Canc Netw; 2019 May 01; 17(5):515-521. PubMed ID: 31085765
    [Abstract] [Full Text] [Related]

  • 15. A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome.
    Rashid MU, Naeemi H, Muhammad N, Loya A, Yusuf MA, Lubiński J, Jakubowska A, Hamann U.
    Hered Cancer Clin Pract; 2016 May 01; 14():14. PubMed ID: 27413415
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN, Hartman R, Pritzlaff M, Horton C, Keith SW.
    JCO Precis Oncol; 2022 May 01; 6(1):e2200234. PubMed ID: 35666082
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.